Novel liposomal combination treatments using dual genes knockdown in oral cancer treatment

Small interfering RNA (siRNA) can be used to treat tumor because it can effectively knockdown target oncoprotein expression and it leads to cancer cell death and apoptosis. Hypoxia-inducible factors-1 (HIF-1) is a transcription factor gene. Its high expression of tumor hypoxia cells, activation of transcription factor HIF-1α and angiogenesis found in most cancerous tissues. HIF-1α protein in cancer cells are critical to cell survival, tumor growth and proliferation. Epidermal growth factor receptor (EGFR) gene is another common head and neck oncogene. The dual self-designed siRNA sequences were encapsulated in the lipid-calcium-phosphate (LCP) and targeted to sigma receptors on the surface of cancer cells via binding to amino ethyl anisamide (AEAA). We used human oral cancer cells to establish the xenograft animal model to study the combination therapy for therapeutic results.

[1]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[2]  Leaf Huang,et al.  Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Pradeep Tyagi,et al.  Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells , 2004, International journal of cancer.

[4]  Peter J Houghton,et al.  Establishment of human tumor xenografts in immunodeficient mice , 2007, Nature Protocols.

[5]  Wei-Hua Chen,et al.  Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer. , 2015, Cancer letters.

[6]  S. Mooring,et al.  HIF-1 inhibitors as anti-cancer therapy , 2011 .

[7]  S. Uprichard.  The therapeutic potential of RNA interference , 2005, FEBS Letters.

[8]  Zuo-Feng Zhang,et al.  Treatment with siRNA and antisense oligonucleotides targeted to HIF‐1α induced apoptosis in human tongue squamous cell carcinomas , 2004, International journal of cancer.

[9]  Geert Carmeliet,et al.  Hypoxia-driven pathways in bone development, regeneration and disease , 2012, Nature Reviews Rheumatology.

[10]  Yu-cheng Tseng,et al.  Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Takeshi Ono,et al.  Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5‐fluorouracil and docetaxel in head and neck squamous cell carcinoma , 2006, Cancer science.

[12]  G. Semenza,et al.  Human Cancers and Their Metastases in Common α Overexpression of Hypoxia-inducible Factor 1 Updated Version , 1999 .

[13]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  M. Detmar,et al.  Findings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Leaf Huang,et al.  Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.